Skip to main content
logo
BioSmart Co.,Ltd. (KOSDAQ:038460)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,610.00
+175.00 (7.19%)
At close: Jul 31, 2026

BioSmart Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
515,820482,776484,310456,164391,822189,183
Revenue Growth
7.93%-0.32%6.17%16.42%107.11%13.67%
Gross Profit
87,96085,25682,26279,00676,72968,436
Operating Income
27,06822,66319,4609,7589,3027,960
Net Income
11,4489,009127.1717,907721.311,392
Earnings Per Share
452.72356.456.00556.8337.5772.53
EPS Growth
-5840.85%-98.92%1382.02%-48.20%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
25,72339,11120,84231,34320,28215,274
Total Debt
77,67075,91964,39788,71883,58173,614
Net Cash (Debt)
-51,948-36,808-43,555-57,375-63,298-58,340
Net Cash Growth
------
Net Cash Per Share
-2054.34-1456.33-2054.95-2255.88-3297.14-3038.88

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
14,73224,0733,7081,1666,2891,203
Capital Expenditures
-37,042-33,245-6,922-3,113-4,359-5,332
Free Cash Flow
-22,310-9,172-3,213-1,9471,930-4,129
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
17.05%17.66%16.98%17.32%19.58%36.18%
Operating Margin
5.25%4.69%4.02%2.14%2.37%4.21%
Pretax Margin
3.66%3.05%1.46%4.64%0.50%0.71%
Profit Margin
2.22%1.87%0.03%3.93%0.18%0.74%
FCF Margin
-4.32%-1.90%-0.66%-0.43%0.49%-2.18%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
5.7710.94612.133.9088.6378.72
P/FCF Ratio
----33.13-
PS Ratio
0.130.200.160.150.160.58